Understanding the Causes, Treatment Options and Saira Health Care’s Integrative Approach

Introduction

Premature ejaculation is one of the most frequently discussed male sexual-health concerns. For some men, the problem is associated with a feeling that the penis—particularly the glans or shaft—is unusually sensitive, causing sexual excitement to rise very rapidly and making ejaculation difficult to control. For others, psychological pressure, erectile difficulties, relationship factors, inflammation, sleep problems, stress, or other medical conditions may contribute.

Because patients often describe this problem as “hypersensitivity,” it is important to understand what the term means in the context of sexual medicine. Penile hypersensitivity is not the same as an allergic or immune-system hypersensitivity reaction. In sexual medicine, it refers to unusually strong sensory responsiveness of the penis that may contribute to rapid ejaculation in a subgroup of men.

The latest 2026 European Association of Urology (EAU) Sexual and Reproductive Health Guidelines underwent a substantial update of the disorders-of-ejaculation section. Current guidance recognizes premature ejaculation as a multidimensional condition involving ejaculation occurring earlier than desired, reduced perceived control, and clinically meaningful distress or interpersonal difficulty. The EAU also recognizes penile hypersensitivity as one proposed biological factor, while emphasizing that premature ejaculation has multiple possible biological and psychological causes.

In a new educational video from Saira Health Care, Dr. Nizamuddin Qasmi discusses penile hypersensitivity, premature ejaculation, sexual control and an individualized traditional approach that includes Dr. Qasmi’s Total Control & Vitality Package.

Watch the complete video on YouTube

View the Total Control & Vitality Package

What Is Premature Ejaculation?

Premature ejaculation, commonly abbreviated as PE, is more than simply ejaculating “quickly.”

Current international guidance emphasizes three major clinical dimensions: how rapidly ejaculation occurs, whether the man feels able to control or delay it, and whether the pattern causes distress, frustration, reduced sexual satisfaction, or relationship difficulty.

The International Classification of Diseases, 11th Revision, uses the term male early ejaculation and describes a pattern in which ejaculation occurs before or within a very short period after relevant sexual stimulation, with little perceived control and clinically significant distress over a sustained period. The EAU similarly recommends that diagnosis should consider ejaculation latency, control, distress and interpersonal consequences rather than relying on a stopwatch alone.

This is particularly important because sexual performance naturally varies.

A man who occasionally ejaculates sooner than expected does not necessarily have a medical disorder.

Premature Ejaculation Can Take Different Forms

Premature ejaculation is not identical in every patient.

Lifelong PE is present from the beginning of a man's sexual life or from his earliest relevant sexual experiences.

Acquired PE develops after a period during which ejaculation was previously satisfactory.

Variable PE refers to occasional or inconsistent early ejaculation and may represent normal variation.

Subjective PE occurs when a man believes that he ejaculates abnormally quickly even though his actual ejaculation time may fall within a typical range. Current European guidance emphasizes that variable and subjective presentations should be distinguished from true persistent pathology.

This classification matters because treatment differs.

A man who has experienced lifelong rapid ejaculation associated with increased genital responsiveness may require a different approach from someone who suddenly develops PE after erectile dysfunction, prostatitis, severe anxiety, or relationship stress.

What Is Penile Hypersensitivity?

Penile hypersensitivity describes a situation in which sexual stimulation of the penis produces an unusually intense sensory response.

A patient may feel that even relatively minor stimulation rapidly pushes him toward ejaculation. Some men describe the glans as “too sensitive,” while others notice excessive sensation along the penile shaft.

Research provides evidence that sensory differences may be relevant in a subgroup of men with primary premature ejaculation, but it also shows that not every man with PE is hypersensitive.

A neurophysiological study of 290 men with primary PE found evidence of increased sensitivity in 141 patients—about 48.6% of that particular study population—while 149 had sensory measurements that were not classified as hypersensitive. Among hypersensitive patients, the abnormal sensory area could involve the glans, shaft, or both.

A subsequent study using the same type of neurophysiological testing found that topical local anaesthetic affected hypersensitive and non-hypersensitive penile regions differently, further supporting the possibility that peripheral sensory mechanisms matter in selected patients.

However, other studies have produced different findings, and an earlier evidence review concluded that published data did not unequivocally establish penile hypersensitivity as the universal cause of PE.

The clinically responsible conclusion is therefore:

Penile hypersensitivity can contribute to premature ejaculation in some men, but it is not the cause in every patient.

Why Can Premature Ejaculation Happen?

The ejaculation reflex involves the brain, spinal cord, peripheral nerves, sensory input from the genital organs, pelvic muscles, hormones, neurotransmitters and psychological arousal.

As a result, premature ejaculation is best understood as a multifactorial sexual disorder.

The 2026 EAU guideline describes several proposed biological and psychological contributors, including penile hypersensitivity, anxiety and altered serotonin-related signalling. Acquired PE can additionally be associated with erectile dysfunction, prostatitis or other genitourinary conditions, hyperthyroidism, relationship or performance anxiety, and poor sleep quality. Other associations reported in the literature include obesity, diabetes, metabolic syndrome, lack of physical activity, emotional stress and depressive symptoms.

This is why simply reducing penile sensation is not enough for every patient.

The Relationship Between Hypersensitivity and Sexual Control

Sexual stimulation generates sensory signals that travel through penile nerves to the spinal cord and brain.

As sexual excitement rises, the body eventually reaches an ejaculatory threshold.

A man who experiences strong sensory stimulation very rapidly may reach this threshold sooner.

But the process is not purely mechanical.

Mental excitement, fear of ejaculating early, performance anxiety and repeated monitoring of one's sexual response can intensify the experience.

For example, a man who constantly thinks:

“I must not ejaculate.”

may become increasingly anxious.

That anxiety may make him monitor every sensation, lose confidence and experience an even stronger subjective sense that ejaculation is approaching.

Effective management therefore frequently requires both physical and psychological strategies.

Premature Ejaculation and Erectile Dysfunction Can Occur Together

Some patients mistakenly believe that premature ejaculation and erectile dysfunction are opposites.

They are not.

A man may experience both conditions simultaneously.

Current EAU guidance notes that a significant proportion of men with erectile dysfunction also report premature ejaculation. Anxiety about losing an erection may cause a man to rush sexual activity, which can aggravate rapid ejaculation.

For acquired PE, current recommendations emphasize treating associated erectile dysfunction or another identifiable sexual or genitourinary disorder first.

This is particularly important when selecting a treatment package.

A patient whose primary problem is hypersensitivity should not automatically receive the same management strategy as someone whose rapid ejaculation is secondary to severe erectile dysfunction.

Psychological Stress and Performance Anxiety

Premature ejaculation can affect confidence considerably.

Men may begin avoiding intimacy, worrying about satisfying their partner, or repeatedly comparing themselves with unrealistic expectations from pornography, social media, advertising, or conversations with friends.

PE itself can then become a cause of anxiety, while anxiety further aggravates the sexual problem.

The EAU reports that PE may negatively affect self-confidence, relationship satisfaction and emotional well-being and can be associated with embarrassment, anxiety and depression.

Current guidelines therefore support psychosexual treatment, especially when anxiety or relationship problems are prominent.

How Premature Ejaculation Should Be Diagnosed

A professional diagnosis normally begins with a detailed medical and sexual history.

The clinician should determine whether the problem is lifelong or acquired, consistent or situational, and whether it occurs during intercourse, masturbation or both.

Erection quality should also be assessed.

Questions about medications, stress, relationship difficulties, urinary symptoms, pelvic pain, thyroid disease, diabetes and other health conditions may be relevant.

Current EAU recommendations emphasize evaluation of self-estimated ejaculation latency, perceived control, distress and interpersonal difficulty. Physical examination may help identify associated urological, endocrine or neurological conditions. Routine laboratory or physiological testing is not necessary for every patient and should generally be guided by specific clinical findings.

This prevents patients from undergoing unnecessary tests simply because they are worried about sexual timing.

What Treatments Are Supported by Modern Guidelines?

Current guideline-based management depends on the type of premature ejaculation and its cause.

For lifelong PE, the EAU recommends dapoxetine or lidocaine/prilocaine spray as first-line pharmacological options, where available and appropriate. Daily SSRIs or clomipramine may be used as alternative treatments under professional supervision. Behavioural and psychological approaches can be combined with pharmacological treatment, particularly in acquired or anxiety-associated cases.

The AUA/SMSNA guideline similarly recommends daily SSRIs, on-demand clomipramine or dapoxetine where available, and topical penile anaesthetics as first-line pharmacological choices.

These treatments require appropriate medical guidance because each has potential adverse effects and contraindications.

Topical Desensitization and Penile Hypersensitivity

When penile sensory input is an important part of PE, topical local anaesthetic treatment can delay ejaculation by reducing sensory transmission.

Lidocaine and prilocaine are well-established topical options.

However, reducing sensation too much can create problems.

The AUA/SMSNA guideline notes that topical anaesthetics can cause significant penile numbness and may also transfer to the sexual partner, producing discomfort or numbness. Condom use or appropriate washing before intercourse may reduce transfer.

This demonstrates an important principle:

The objective is not to eliminate penile sensation. It is to achieve better ejaculatory control while maintaining satisfactory sexual pleasure and erection.

Behavioural and Psychosexual Approaches

Medication is not the only treatment.

Current European guidance discusses approaches such as sexual education, stop-start exercises, mindfulness, behavioural therapy and couple-based intervention.

These methods aim to teach better recognition of rising arousal, improve confidence, reduce performance anxiety and improve communication between partners.

Evidence suggests that combining psychosexual strategies with appropriate pharmacological management may provide better overall results in selected patients than relying on medication alone.

This combined approach is particularly relevant to the philosophy behind individualized Unani sexual-health management.

The Unani Perspective on Hypersensitivity and Premature Ejaculation

Unani medicine has traditionally approached sexual disorders through the overall functional state of the individual.

Rather than focusing solely on how many seconds intercourse lasts, a Unani physician may consider Mizaj or temperament, physical strength, nervous excitability, diet, sleep, emotional condition, digestion, sexual habits and associated reproductive symptoms.

Traditional Unani literature describes premature ejaculation under concepts such as Sur‘at-e-Inzal, and excessive genital sensitivity has been discussed under Zakawat-e-Hiss.

The traditional framework and modern neurophysiology are not identical scientific models.

However, both recognize that some men appear to have an unusually rapid response to genital stimulation.

The useful contemporary approach is therefore to combine the individualized philosophy of Unani medicine with modern diagnostic information rather than claiming that the two systems describe exactly the same biological mechanism.

Why an Individualized Unani Approach Can Be Useful

The strength of Unani management lies in its whole-person approach.

A patient may present with premature ejaculation together with poor sleep, chronic stress, digestive disturbance, low confidence, fatigue or another sexual complaint.

Unani treatment may incorporate diet, lifestyle regulation, patient counselling and selected traditional formulations according to the individual's condition.

At the same time, important modern medical diagnoses should not be overlooked.

A man with prostatitis requires appropriate evaluation of the infection or inflammation.

A patient with significant erectile dysfunction requires ED assessment.

A man with hyperthyroidism needs appropriate endocrine management.

Traditional treatment works most responsibly when it complements diagnosis rather than replacing it.

Introducing Dr. Qasmi’s Total Control & Vitality Package

Saira Health Care Pharmacy currently offers a product officially titled Dr. Qasmi’s Total Control & Vitality Package for Hypersensitivity Relief & Premature Ejaculation Cure.

According to the product page, the package is supplied as a one-month medicine package and combines three products intended to address different aspects of male sexual wellness.

The package contains:

• Dr. Qasmi’s Nuskha No. 104 – Vitaflow Max: an externally applied oil positioned by the pharmacy for penile hypersensitivity and local sexual-health support.
• Dr. Qasmi’s Nuskha Imsak: an oral capsule positioned for ejaculatory control, sexual vitality and associated erectile concerns.
• Dr. Qasmi’s Nuskha No. 108: a traditional Majoon formulation positioned as supportive for stamina, physical strength and general vitality. 

View full package details and current product information

Why the Package Uses More Than One Formulation

The concept behind a multi-product package is to address more than one aspect of the patient's complaint.

According to Saira Health Care Pharmacy, Vitaflow Max is intended for external use, while Nuskha Imsak and Nuskha No. 108 provide internal traditional support. The pharmacy describes the package as targeting hypersensitivity, control, stamina and sexual vitality through this combined approach.

From a clinical perspective, however, combining several products does not mean that every patient needs all of them.

A professional assessment remains important because the dominant cause of premature ejaculation varies.

Nuskha No. 104 – Vitaflow Max

The package product page describes Nuskha No. 104 – Vitaflow Max as an externally applied oil intended primarily for hypersensitivity and blood-flow support. Listed ingredients include Kharateen Mussaffa, Roghan Shersaf and Roghan Kunjad.

External treatment may make conceptual sense when excessive peripheral sensitivity is considered important.

However, patients should not assume that stronger desensitization always produces better sexual performance.

Too little sensation can reduce pleasure, make orgasm difficult or adversely affect sexual satisfaction.

Correct quantity, method and duration of use should therefore follow professional instructions.

Nuskha Imsak

The package also contains Dr. Qasmi’s Nuskha Imsak, which Saira Health Care Pharmacy positions for premature ejaculation, sexual control and associated erectile concerns.

The package page lists ingredients including Ashwagandha, Swarn Bhasm, Tribang Bhasm and Asparagus racemosus.

An important accuracy point follows from this ingredient list: because the formulation includes bhasma/mineral preparations, descriptions such as “100% herbal” should be interpreted cautiously. It is more accurate to describe the package as a traditional Unani/Ayurvedic formulation package containing botanical and traditional processed ingredients, according to its published composition.

Such medicines should be used under professional supervision, especially when a patient is taking other medications or has chronic medical conditions.

Nuskha No. 108

The third component is Dr. Qasmi’s Nuskha No. 108, presented as a traditional Majoon or herbal paste.

According to the package page, ingredients include Salab Misri, pine nuts, saffron, honey and ginger, and the formulation is positioned to support stamina and general physical vitality.

This part of the package is better understood as general wellness and stamina support rather than a proven stand-alone treatment for the neurological mechanism of premature ejaculation.

Can the Total Control & Vitality Package “Cure” Premature Ejaculation Permanently?

The word “cure” should be used carefully.

Premature ejaculation is treatable, and many men can achieve meaningful improvements in ejaculation latency, perceived control, sexual confidence and relationship satisfaction.

However, neither modern nor traditional treatment can responsibly guarantee a permanent cure for every patient.

Current international guidelines acknowledge effective pharmacological and behavioural treatments but also note that long-term outcomes vary and that PE can arise through several different mechanisms.

For a professional medical website, the most accurate phrasing is:

“Treatment or support for premature ejaculation and hypersensitivity,”

rather than guaranteeing universal permanent cure.

Is the Package Clinically Proven?

The Saira Health Care Pharmacy page contains multiple product-benefit claims for the package. These should be understood as manufacturer/clinic product descriptions. The current publicly accessible product page does not provide randomized controlled trials specifically demonstrating that this three-product package permanently cures premature ejaculation or penile hypersensitivity.

This does not mean that an individual patient cannot report benefit.

It means that individual clinical experience and product positioning should be distinguished from the level of evidence required to establish a treatment as independently proven in large controlled studies.

That distinction is important for maintaining professional medical credibility.

“Natural” Does Not Automatically Mean No Side Effects

One of the most common misconceptions in traditional medicine is that natural products cannot cause side effects.

Plants and traditional mineral preparations contain biologically active substances.

Their safety depends on dose, quality, individual health conditions, interactions with other medicines and appropriate manufacturing standards.

The same principle applies to conventional medicines.

A responsible patient should tell the treating clinician about all prescription drugs, supplements, traditional medicines and external products being used.

Who May Benefit From Professional Evaluation for This Package?

The package may be considered as part of an individualized traditional approach when a man reports hypersensitivity, early ejaculation, poor perceived control, sexual anxiety or reduced stamina.

However, professional assessment becomes particularly important when PE is newly acquired, erectile dysfunction is also present, urinary burning or pelvic pain exists, ejaculation suddenly changes, diabetes or thyroid disease is present, medication use may be contributing, or relationship and psychological problems are significant.

The purpose of assessment is not merely to decide which medicine to sell.

It is to understand which condition actually needs treatment.

When Premature Ejaculation Is Caused by Another Condition

For acquired PE, current EAU guidance specifically recommends treating underlying conditions such as erectile dysfunction, other sexual dysfunction or genitourinary infection first.

For example, if a patient develops premature ejaculation because he is afraid of losing his erection, improving erectile function may be more important than aggressively reducing penile sensitivity.

If prostatitis is causing new sexual symptoms, inflammation or infection should be managed appropriately.

If anxiety is dominant, psychosexual counselling may be a central part of treatment.

This reinforces the value of individualized care.

What Men Can Do Alongside Treatment

Long-term sexual health depends on more than medication.

Regular exercise, adequate sleep, healthy weight, smoking cessation, moderation of excessive alcohol, management of diabetes and other chronic diseases, psychological stress reduction and good communication with one's partner can all support sexual well-being.

The AUA/SMSNA guideline also highlights associations between PE and erectile dysfunction, metabolic syndrome, sedentary lifestyle, body weight and alcohol use and encourages healthy lifestyle choices.

Lifestyle improvement should therefore be viewed as part of a complete treatment programme rather than an optional extra.

The Importance of Managing Expectations

Sexual-health advertising often promotes unrealistic promises such as:

“Permanent timing.”

“Guaranteed one-hour performance.”

“Zero side effects.”

“100% cure.”

These claims can create anxiety rather than relieve it.

There is no single “correct” duration of intercourse that applies to every couple.

The goal of PE treatment should be more meaningful:

better control, lower distress, greater confidence and improved satisfaction for the patient and partner.

This is consistent with modern diagnostic standards, which evaluate perceived control and distress alongside ejaculation latency.

Dr. Nizamuddin Qasmi and the Saira Health Care Approach

Saira Health Care identifies Dr. Nizamuddin Qasmi as its founder and chief physician and describes the clinic as a registered Unani centre focused on sexual disorders and infertility.

The clinic states that its approach combines traditional Unani principles with modern diagnostic information, nutritional advice, lifestyle modification and individualized treatment planning. It also describes Dr. Qasmi's clinical focus as including premature ejaculation, erectile dysfunction and male infertility.

This type of approach is particularly relevant for premature ejaculation because the disorder can involve physical, sensory, psychological and relationship factors simultaneously.

The objective should therefore be to treat the patient rather than simply treat a stopwatch reading.

Educational Role of Saira Health Care

Many men delay seeking treatment because they feel embarrassed discussing premature ejaculation.

Others rely on misleading online information or purchase random products without understanding whether hypersensitivity, anxiety, erectile dysfunction or another problem is responsible.

Patient education can prevent this pattern.

Saira Health Care describes its mission as providing a non-judgmental environment for discussing sexual and infertility concerns and using individualized treatment rather than a one-size-fits-all model.

Education is particularly important because premature ejaculation should never be viewed as a failure of masculinity.

It is a recognized sexual-health condition that can often be managed.

Watch the Complete Educational Video

The latest video discusses the concept of Total Control & Vitality, penile hypersensitivity, premature ejaculation, ejaculatory control and the role of Dr. Qasmi’s specialized medicine package.

Watch the video: Total Control & Vitality Package

The video is intended to help patients understand why premature ejaculation can occur and why treatment should be selected according to the patient's actual symptoms and underlying condition.

Total Control & Vitality Package

For complete information about the package, its components, current price, dosage instructions and ordering information:

Dr. Qasmi’s Total Control & Vitality Package

The product page currently describes the package as containing Nuskha No. 104 – Vitaflow Max, Nuskha Imsak and Nuskha No. 108.

For More Information

For professional information related to male sexual health, premature ejaculation, erectile dysfunction and infertility:

Visit Saira Health Care

For medicine information and online orders:

Visit Saira Health Care Pharmacy

For regular educational videos:

Subscribe to Saira Health Care on YouTube

For regular health news and updates:

Follow the Saira Health Care WhatsApp Channel

Conclusion

Premature ejaculation is not simply a problem of “weakness,” and penile hypersensitivity is not the explanation for every patient.

Modern sexual medicine recognizes PE as a multidimensional condition involving early ejaculation, reduced perceived control and distress. Biological factors such as penile sensory responsiveness and serotonin-related pathways may contribute, while acquired PE may be associated with erectile dysfunction, anxiety, prostatitis, hyperthyroidism, poor sleep and other conditions.

Research confirms that penile hypersensitivity exists in a subgroup of patients. In one neurophysiological study involving 290 men with primary PE, about 48.6% demonstrated hypersensitivity, while more than half did not. This finding highlights why individual diagnosis matters.

Modern guideline-supported treatments include dapoxetine where available, topical lidocaine/prilocaine treatment, selected SSRIs or clomipramine under professional guidance, and behavioural or psychosexual treatment. Associated erectile dysfunction, infection or another underlying disorder should be managed appropriately.

Unani medicine can provide an additional individualized framework through its attention to Mizaj, physical vitality, diet, sleep, lifestyle, psychological condition and sexual habits.

Within this context, Dr. Qasmi’s Total Control & Vitality Package combines Nuskha No. 104 – Vitaflow Max, Nuskha Imsak and Nuskha No. 108 as part of Saira Health Care Pharmacy's traditional approach to hypersensitivity, ejaculatory control and sexual vitality.

However, maintaining professional medical accuracy is essential. No package should be represented as guaranteeing permanent cure or identical results for every man, and no traditional product should automatically be described as completely free from possible side effects.

The most appropriate message for men concerned about premature ejaculation is:

Understand the cause. Improve control. Address hypersensitivity when it is genuinely present. Treat associated sexual or medical conditions. Reduce performance anxiety. Follow an individualized treatment plan rather than relying on unrealistic promises.

That approach provides a stronger foundation for lasting sexual confidence and overall male sexual well-being.

Medical Disclaimer

This article and associated video are intended for general health education and sexual-health awareness only. They do not replace an individualized medical consultation, diagnosis, examination or treatment by an appropriately qualified healthcare professional.

Premature ejaculation may have different biological, psychological, relationship-related and medical causes. Treatment should therefore be tailored to the individual.

Traditional, herbal, Unani and Ayurvedic formulations can contain biologically active botanical or mineral ingredients and should be used according to professional guidance. No medicine, supplement, oil, capsule or treatment package can responsibly guarantee permanent cure, a specific intercourse duration or complete absence of adverse effects for every patient.